Danazol (AvKARE, Inc.)


Welcome to the PulseAid listing for the Danazol drug offered from AvKARE, Inc.. This Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AvKARE, Inc.
NON-PROPRIETARY NAME: Danazol
SUBSTANCE NAME: DANAZOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-02-23
END MARKETING DATE: 0000-00-00


Danazol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDanazol from AvKARE, Inc.
LABELER NAME: AvKARE, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 2016-02-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42291-243_5df42da0-05dd-97a8-a68b-332bb243f3b2
PRODUCT NDC: 42291-243
APPLICATION NUMBER: ANDA074582

Other DANAZOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AvKARE, Inc.Danazol
Carilion Materials ManagementDanazol
Lannett Company, Inc.Danazol
Teva Pharmaceuticals USA, Inc.Danazol